Author

Li-Ting Kao

Institutions: Tri-Service General Hospital, National Defense Medical Center

Observed institutions: Tri-Service General Hospital, National Defense Medical Center

ORCID: 0000-0003-0692-7408

Observed ORCID: 0000-0003-0692-7408

OpenAlex ID: A5111243242

Psoriasis Risk With Immune Checkpoint Inhibitors

2024 · Sheng-Yin To, Cho-Hao Lee, et al. · JAMA Dermatology · 16

Autoimmune Skin Diseases and Survival Outcomes After Antineoplastic Treatment in Patients With Cancer

2025 · Sheng-Yin To, Cho-Hao Lee, et al. · JAMA Dermatology · 3

Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor–Mutant Non–Small Cell Lung Cancer

2026 · Po-Huang Chen, Hong-Jie Jhou, et al. · JCO Oncology Practice

Breast Radiotherapy and Risk of Hematologic Malignancies: A Target Trial Emulation Using Real-World Data

2026 · Cho-Hao Lee, Wei-Cheng Chang, et al. · SSRN Electronic Journal

Rwd242 Proposal of Using Claims-based Diagnoses and Prenatal Examinations to Identify Pregnancy in Taiwan: National Health Insurance Research Database

2025 · Hung-Wei Lin, Yu-Hsuan Kuo, et al. · Value in Health Regional Issues

Works count: 5

Citation count: 19

H-index: 2

I10-index: 1